
Endo, Inc. to Sell International Pharmaceuticals Business to Knight Therapeutics
MALVERN, PA — Endo, Inc. (OTCQX: NDOI) has announced a definitive agreement to divest its International Pharmaceuticals business, operated primarily through Canada-based Paladin Pharma Inc., to Knight Therapeutics Inc. The deal, …
Endo, Inc. to Sell International Pharmaceuticals Business to Knight Therapeutics Read More